Latest AI and machine learning research in dementia for healthcare professionals.
Alzheimer’s disease (AD) is a major global health concern, expected to affect 12.7 million Americans...
Single-omics approaches often provide a limited perspective on complex biological systems, whereas m...
Alterations in metabolism, stress response, sleep, circadian rhythms, and neuroendocrine processes a...
Predicting symptom onset in genetic frontotemporal dementia (FTD) is crucial for advancing targeted ...
Olfactory dysfunction is a frequent yet understudied feature of neurodegenerative spectrum disorders...
Digital language markers show promise in detecting early cognitive impairment related to Alzheimer’s...
Hyaluronan and proteoglycan link protein 2 (HAPLN2) / Brain link protein-1 (Bral1) is important for ...
Plasma proteomics captures a functional snapshot of human physiology; yet, most machine learning mod...
Single-cell RNA sequencing (scRNA-seq) has significantly advanced our understanding of Alzheimer’s d...
Proteostasis dysfunction is a hallmark of frontotemporal dementia (FTD) and Alzheimer’s disease (AD)...
Alzheimer’s disease (AD) is characterized by progressive cognitive decline and increased seizure sus...
Leveraging machine learning on electronic health records offers a promising method for early identif...
Physical activity is essential for preventing cognitive decline, stroke and dementia in older adults...
Rapid developments are occurring in artificial intelligence (AI) and machine learning (ML) applied t...
Parkinson’s disease (PD) exhibits a variety of symptoms, with approximately 25% of patients experien...
Frontotemporal lobar degeneration-TDP Type C (TDP-C) is a unique neurodegenerative disease that star...
Alzheimer’s disease (AD) presents a critical global health challenge, with current therapies offerin...
Characterizing the cardinal neuropathologies in Alzheimer disease (AD) can be laborious, time consum...
INTRODUCTION: Artificial intelligence and neuroimaging enable accurate dementia prediction, but ‘bla...
Despite the ongoing opioid epidemic, the mortality risk of opioid initiation in patients with dement...
Alzheimer’s Disease (AD) patients at multiple stages of disease progression have a high prevalence o...